Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07215481 · ClinicalTrials.gov registry record · NA
Automated Image-Guided Programming of Deep Brain Stimulation (DBS) for Parkinson's Disease
A NA study, sponsored by Stanford University.
- Not yet
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT07215481: Clinical Trial NA study, sponsored by Stanford University.
NCT07215481 is a NA study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07215481, a NA study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to evaluate an automated deep brain stimulation (DBS) algorithm developed by Boston Scientific called Illumina 3D for motor symptoms in Parkinson's disease (PD). The main question it aims to answer is: Is this new automated algorithm effective for treating motor symptoms of PD. Fifteen participants are anticipated to be enrolled. Participants are individuals who recently were implanted with DBS in the subthalamic nucleus as part of their regular clinical treatment and are scheduled to have their DBS turned ON for the first time. In addition to their regular clinical visit when their DBS is turned ON by their clinician, participants are tested on DBS settings determined by Illumina 3D (an automated algorithm). Participants are tested on these different settings across different motor tasks, including walking and finger tapping, as well as answering questionnaires. The experiment is expected to last 1 or 2 days; this is not a longitudinal or long-term trial. Participants return to their usual DBS settings once they leave the clinic.
Interventions
- DEVICE Shame Control (Baseline)
- DEVICE Standard of Care Deep Brain Stimulation
- DEVICE Illumina 3D Deep Brain Stimulation
- DEVICE Illumina 3D Deep Brain Stimulation Reduced Amplitude
- DEVICE Illumina 3D Deep Brain Stimulation Higher Amplitude
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2026-06 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07215481
The ClinicalTrials.gov registry entry for NCT07215481 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Shame Control (Baseline) is the first listed.
NCT07215481 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07215481 about?
NCT07215481 is a clinical study titled "Automated Image-Guided Programming of Deep Brain Stimulation (DBS) for Parkinson's Disease". The goal of this clinical trial is to evaluate an automated deep brain stimulation (DBS) algorithm developed by Boston Scientific called Illumina 3D for motor symptoms in Parkinson's disease (PD). The main question it aims to answer is: Is this new automated algorithm effective for treating motor sy...
What is the current status of trial NCT07215481?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2026-06. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07215481?
The interventions under investigation include: Shame Control (Baseline) (DEVICE), Standard of Care Deep Brain Stimulation (DEVICE), Illumina 3D Deep Brain Stimulation (DEVICE), Illumina 3D Deep Brain Stimulation Reduced Amplitude (DEVICE), Illumina 3D Deep Brain Stimulation Higher Amplitude (DEVICE).
Who is sponsoring clinical trial NCT07215481?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.